Axisgroup
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Australia & New Zealand Diagnostic Imaging Equipment Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 80 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 80 pages
- Published: 07-06-2019
Market Overview
Diagnostic imaging is the process where the internal structure of human body is viewed using the electromagnetic radiation, for accurate diagnosis of the patient. The diagnostic imaging uses radiations to diagnose and treat the diseases. There are various modalities in the medical imaging, the most common ones being the CT scan and MRI systems. The market studied is driven by several factors, such as growing technological advancements, including handheld X-ray and upright MRI, and increasing interest among researchers regarding medical imaging equipment. Additionally, increase in chronic diseases and increasing government funding pertaining to diagnostic imaging studies are also responsible to drive the growth of the market studied.
Scope of the Report
This report includes an in-depth study of the Australia & New Zealand diagnostic imaging equipment market (henceforth, referred to as the market studied). Diagnostic imaging is used to take images of the internal structure of human body, using electromagnetic radiation, for accurate diagnosis of the patient. There are various modalities in medical imaging, the most common ones being CT scan and MRI systems.
Key Market Trends
X-ray Equipment Segment Captures the Largest Market Share and is Expected to Retain its Dominance over the Forecast Period
An X-ray is a non-invasive medical test that helps physicians diagnose and treat medical conditions. Imaging with X-rays involves exposing a part of the body to a small dose of ionizing radiation to produce pictures of the inside of the body. Chest X-rays are the most frequently ordered imaging test in Australian general practice. They were generally accounted for 8.3% of all imaging tests ordered by general practitioners in 2013and 14. In addition, there is also a rising need for radiographers in Australia that is expected to boost the Australian market. Recently, in 2018, the New Zealand scientists have been found performing the first 3-D, color X-ray on a human, using a technique that promises to improve the field of medical diagnostics. Hence, these technologies are also being commercialized by the New Zealand company, MARS Bioimaging, and may increase the overall market.
Competitive Landscape
The presence of major market players, such as Canon Medical Systems Ltd, Carestream Health, GE Healthcare, Koninklijke Philips NV, and Siemens Healthineers, is expected to increase the overall market competition. Companies are trying to gain a sustainable competitive advantage through innovation, while maintaining their consumer base through interactive upgrades in product segments. There is significant competition on the basis of product innovation, connectivity, and ease of operation in the portable diagnostic imaging equipment segment.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Awareness Regarding Preventive Care
4.2.2 Technological Advancements
4.2.3 Growth in the Incidences of Various Diseases
4.3 Market Restraints
4.3.1 High Cost of Advanced Diagnostic Imaging Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 X-ray Equipment
5.1.2 Ultrasound
5.1.3 Magnetic Resonance Imaging (MRI)
5.1.4 Mammography
5.1.5 Computed Tomography
5.1.6 Nuclear Medicine
5.1.6.1 Positron Emission Tomography (PET)
5.1.6.2 Single Photon Emission Computerized Tomography (SPECT)
5.2 Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Other Applications
5.3 End Users
5.3.1 Hospital
5.3.2 Diagnostic Center
5.3.3 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Ltd
6.1.2 Carestream Health
6.1.3 Esaote
6.1.4 Fujifilm Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Corporation
6.1.7 Hologic Inc.
6.1.8 Koninklijke Philips NV
6.1.9 Siemens Healthcare GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
X-ray Equipment
Ultrasound
Magnetic Resonance Imaging (MRI)
Mammography
Computed Tomography
Nuclear Medicine
Positron Emission Tomography (PET)
Single Photon Emission Computerized Tomography (SPECT)
Application
Cardiology
Oncology
Neurology
Orthopedics
Other Applications
End Users
Hospital
Diagnostic Center
Other End Users
Healthcare IT Integration Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 119 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 119 pages
- Published: 07-06-2019
Market Overview
The global healthcare IT integration market was valued at USD 2,180.26 million in 2018, and is estimated to be valued at USD 3,973.32 million in 2024, witnessing a CAGR of 10.52%. The market is being driven by factors, such as the need to build a single platform for patients’ records and other healthcare providers, need to increase the efficiency of current medical practices and institutions, need to cut or contain healthcare expenditure, and rise in the demand for paperless technology.
The expenditure on health per capita in developed regions, such as North America and Europe, is already very high and is increasing rapidly in some regions. For instance, as per the report of CMS, the healthcare spending in the United States increased by 3.9% to reach USD 3.5 trillion, or USD 10,739 per person in 2017. Emerging economies, such as India, which already spend a lesser percentage of GDP on healthcare, are also looking for budget cut and one of the ways to go ahead is by introducing IT in healthcare. If these countries have to move toward less expenditure on healthcare, then they have to implement a more focused healthcare policy. For any policy to be implemented, comprehensive data is required about the past and present conditions and projection for the future, which is acutely missing in these countries.
In many of the instances, patients are asked to go for some tests and costs associated with them are really high. These tests may have been performed earlier by some other doctor at another lab, however, due to lack of a proper database for patient information, in most of the cases, patients have to go for the repetitive test. This is again adding to the overall healthcare cost. Use of IT in healthcare and integrating with other medical departments can minimize such repetitive tests by creating a comprehensive database for patients’ information, such as Electronic Medical Record (EMR). This indicates that there is a rising need to inculcate some modifications in the healthcare cost structure, which can be achieved by incorporating healthcare integration tools at the point of care.
Scope of the Report
Healthcare IT integration is defined as integrating information technology (IT) with operations in healthcare. The integration of information technology (IT) in healthcare includes a variety of automated methods that are used to manage information about people’s health and healthcare, for both individual and group of patients.
Key Market Trends
Interface Engines is Expected to hold the Highest Market Share in the Product Segment
In the product segment of the healthcare IT integration market, interface engines are believed to have the largest market size and are expected to witness a CAGR of 10.78% during the forecast period.
An interface engine, also known as an integration engine, is a software program that processes the data between various healthcare IT systems. These integration engines help IT departments tie together disparate systems, allowing the clinicians and other authorized users to access data housed within multiple EHRs or other applications. The role of an interface engine is to ease the workflow by providing flexibility to change direction and send alerts when any abnormal condition arises. Streamlined healthcare workflows and interface engines are a vital combination of support and delivery of the products. Some of the top interface engines found are Cloverleaf, Corepoint, Rhapsody, Datagate, and IGUANA. The interface engines are, thus, found to be less expensive and take less time to initially implement because an engine allows for the leveraging of data. An engine is flexible in its acceptance of data.
With the rising significance of the interface engine, there is a rapid future growth estimated for this segment.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for healthcare IT integration and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the well-established healthcare industry and better reimbursement facilities in the region. The United States holds the majority of the market in the North American region, due to the higher adoption of digital healthcare in the country and the rising investments done by the companies over there.
Competitive Landscape
The healthcare IT integration market is highly competitive and consists of several major players. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new ingredients with lesser prices. Companies, like Allscripts Healthcare Solutions Inc., Cerner Corporation, GE Healthcare, and IBM Corporation, hold a substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Need to Build a Single Platform for Patient’s Record and Other Healthcare Providers
4.2.2 Need to Increase Efficiency of Current Medical Practices and Institution
4.2.3 Need to Cut or Contain Healthcare Expenditure
4.2.4 Rise in the Demand for Paperless Technology
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals in Healthcare
4.3.2 High Maintenance and Security Cost
4.4 Industry Attractiveness- Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Interface Engines
5.1.2 Medical Device Integration Setup
5.1.3 Other Products
5.2 By Mode of Service
5.2.1 Operation Services
5.2.2 Support and Upkeep Services
5.2.3 Training
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Labs
5.3.4 Radiology
5.3.5 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allscripts Healthcare Solutions Inc.
6.1.2 Cerner Corporation
6.1.3 GE Healthcare
6.1.4 IBM Corporation
6.1.5 Siemens Healthcare GmbH
6.1.6 Corepoint Health LLC
6.1.7 InterSystems Corporation
6.1.8 Oracle Corporation
6.1.9 Orion Health
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Interface Engines
Medical Device Integration Setup
Other Products
By Mode of Service
Operation Services
Support and Upkeep Services
Training
By End User
Hospitals
Clinics
Labs
Radiology
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Healthcare IT Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 116 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 07-06-2019
Market Overview
The global healthcare IT market was valued at USD 75,080.5 million in 2018, and is estimated to be valued at USD 15,0474.78 million in 2024, witnessing a CAGR of 12.29%. The rise in the demand for paperless technology, the emergence of social media and its impact on the healthcare IT industry are some of the major factors responsible for the current growth of the market studied. Along with these, increased funding from governments, various initiatives taken by the associations for the improvement of healthcare services and infrastructure, and a good return on investments are the other factors augmenting the growth of the market.
In today’s changing healthcare landscape, the usage of internet and social media has become important to develop a better understanding of healthcare information technologies and their impact on health communication. From 2005 to 2017, the participation in social networking sites had more than quadrupled and the adoption rate had gone high, which showed a positive impact on the growth of the market studied. According to CMS, the US National health expenditures represent approximately 18% of the GDP (Gross Domestic Product), which is expected to reach roughly 20%, by 2020. The majority of the growth is anticipated to be fuelled by public sector spending, specifically by Medicare and Medicaid. Medicaid and social security are expected to exceed government revenues. Thus, increasing investments in healthcare are likely to drive product innovation and technology acceptance, which, in turn, may propel the market studied, globally.
Scope of the Report
According to the United States Department of Health and Human Services, healthcare IT is defined as the application of information processing involving both computer hardware and software that deals with the storage, retrieval, sharing, and use of healthcare information, data, and knowledge for communication and decision-making. The main goal of the health information technology market is to maintain records containing the patients’ health information and delivering it to doctors, patients, or their families, in a safe and efficient way.
Key Market Trends
Services Sub-segment is Expected to hold its Highest Market Share in the Component Segment
In the component segment of the healthcare IT market, services are believed to have the largest market size and are expected to witness a CAGR of 12.77% during the forecast period.
The services sub-segment includes both support and maintenance and professional services. The services sub-segment held the largest market share in 2017 and is expected to grow significantly during the forecast period. Since the implementation of IT in healthcare, the amount of data has been increasing continuously; the storage and maintenance costs of data have increased over the last few years. Additionally, healthcare institutions lack skilled IT professionals to handle this huge amount of data. Hence, the increasing cost, along with lack of skilled professionals, has compelled several institutions to opt for the maintenance and support services provided by healthcare IT companies.
In addition to the maintaining and supporting services, analytics, which holds a significant market share, is also being provided by the leading players, such as IBM, GE Healthcare, Philips, etc. With the emergence and introduction of cloud-based technology in healthcare, the share of the services sub-segment has gone up significantly.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America, being the developed region, is currently dominating the market for healthcare IT and is expected to continue to hold the large market share for a few more years. The major factors responsible for the region’s largest market share in the future are the well-established healthcare industry and better reimbursement facilities in the region. The United States holds the majority of the market in the North American region; this is due to the higher adoption of digital healthcare in the country and the rising investments done by the companies over there.
Competitive Landscape
The healthcare IT market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new services at affordable prices. Companies, like GE Healthcare, Philips Healthcare, Siemens Healthcare, Cerner Corporation, and Allscripts Healthcare Solutions Inc., hold a substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Demand for Paper-less Technology
4.2.2 Emergence of Social Media and its Impact on the Healthcare IT Industry
4.2.3 Increased Government Funding on Healthcare Services and Infrastructure
4.2.4 Good Return of Investments (ROI)
4.3 Market Restraints
4.3.1 Lack of Skilled Labor
4.3.2 High Maintenance Costs
4.3.3 Reluctance to Shift to New Technology
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Business Segment
5.1.1 Hospital Information Systems (HIS)
5.1.2 Laboratory Information Systems (LIS)
5.1.3 Clinical Information Systems (CIS)
5.1.4 Radiology Information Systems (RIS)
5.1.5 Cardiovascular Information System (CVIS)
5.1.6 Electronic Health Records (EHR)
5.1.7 Telemedicine
5.1.8 Vendor Neutral Archive (VNA)
5.1.9 Picture Archiving and Communication System (PACS)
5.1.10 Clinical Decision Support System (CDSS)
5.1.11 Other Business Segments
5.2 By Component
5.2.1 Software
5.2.2 Hardware
5.2.3 Services
5.3 By Delivery Mode
5.3.1 On-premise
5.3.2 Cloud-based
5.4 By End User
5.4.1 Payers
5.4.2 Providers
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Philips Healthcare
6.1.3 Siemens Healthcare
6.1.4 Cerner Corporation
6.1.5 Allscripts Healthcare Solutions Inc.
6.1.6 Wipro
6.1.7 Oracle Corporation
6.1.8 IBM
6.1.9 SAS Institute Inc.
6.1.10 Dell Technologies Inc.
6.1.11 Mckesson Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Business Segment
Hospital Information Systems (HIS)
Laboratory Information Systems (LIS)
Clinical Information Systems (CIS)
Radiology Information Systems (RIS)
Cardiovascular Information System (CVIS)
Electronic Health Records (EHR)
Telemedicine
Vendor Neutral Archive (VNA)
Picture Archiving and Communication System (PACS)
Clinical Decision Support System (CDSS)
Other Business Segments
By Component
Software
Hardware
Services
By Delivery Mode
On-premise
Cloud-based
By End User
Payers
Providers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Artificial Organ Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 119 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 119 pages
- Published: 07-06-2019
Market Overview
The global artificial organ market was valued at USD 29,366.67 million in 2018, and is estimated to be valued at USD 44,899.44 million in 2024, witnessing a CAGR of 7.33%. Factors that are driving the market include the rising geriatric population, scarcity of donor organs, and technological advancements in the artificial organ sector.
Advances in medicine and technology and increased awareness about organ donation and transplantation have contributed to a record number of transplants. But the gap between supply and demand continues. According to the US Government Information on Organ Donation and Transplantation, more than 114,000 patients are on the national transplant waiting list, as of December 2018, and on an average, every 10 minutes, another person is added to the waiting list. 34,770 transplants were performed in 2017, and as of November 2018, a total of 33,431 transplants have been performed in 2018. 95% of US adults support organ donation, but only 54% are actually signed up as donors; only three in 1,000 people die in a way that allows for organ donation. The situation is even direr in countries, such as Japan and South Korea, where the organ donation rates are very low. Hence, the scarcity of donor organs is propelling the demand for artificial organs.
Scope of the Report
An artificial organ is a medical device that is implanted or integrated into the body to replicate or augment the natural function of the organ. As per the scope of the report, artificial organs include implantable devices, such as fully artificial hearts and pacemakers, along with organ support machines, such as dialysis and extracorporeal membrane oxygenation (ECMO) machines.
Key Market Trends
Artificial Kidney is Expected to hold its Highest Market Share in the Organ Type
In the organ type segment of the market, an artificial kidney is believed to have the largest market size and is expected to witness a CAGR of 6.21% during the forecast period.
More than 650,000 patients, per year, in the United States and an estimated 2 million patients worldwide are affected by end-stage renal disease (ESRD). Those who live with ESRD make only 1% of the Medicare-covered population, but account for 7% of the Medicare budget. The number of patients in the United States diagnosed with ESRD is increasing by 5% each year. Mortality rates vary depending on the ESRD treatment. After one year of treatment, those on dialysis have a 20-25% mortality rate, with a five-year survival rate of 35%. People who receive transplants have a 3% mortality rate after five years.
As the rate of mortality because of dialysis is increasing, there is increased demand for artificial kidneys, which is propelling the growth of this segment.
North America Dominates the Market and is Expected to Continue its Dominance in the Forecast Period
North America currently dominates the market for artificial organs, and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to increased demand for artificial organs. The United States spends a significant parentage of its GDP each year on healthcare. According to the recent report of the Organization for Economic Co-operation and Development (OECD), 2018, about 18% of the GDP is spent on healthcare. Out of this, a substantial part goes into transplants being performed in the United States. Therefore, the United States holds the largest share in the artificial organ market in the North American region.
Competitive Landscape
The artificial organ market is moderatley competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with less prices. Companies, like B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Getinge AB, and Medtronic PLC, hold the substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Rising Geriatric Population
4.3.2 Scarcity of Donor Organs
4.3.3 Technological Advancements in the Artificial Organ Sector
4.4 Market Restraints
4.4.1 Expensive Procedures
4.4.2 Risks Associated With Artificial Organs
4.5 Industry Attractiveness – Porter’s Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Organ Type
5.1.1 Artificial Heart
5.1.1.1 Prosthetic Heart Valves
5.1.1.2 Ventricular Assist Devices
5.1.1.3 Cardiac Pacemakers
5.1.2 Artificial Kidney
5.1.3 Artificial Pancreas
5.1.4 Artificial Lungs
5.1.5 Cochlear Implants
5.1.6 Other Organ Types
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Baxter International Inc.
6.1.3 Boston Scientific Corporation
6.1.4 Getinge AB
6.1.5 Medtronic PLC
6.1.6 Abiomed
6.1.7 Asahi Kasei Medical Co. Ltd
6.1.8 Berlin Heart GmbH
6.1.9 Carmat SA
6.1.10 Edward Lifesciences Corporation
6.1.11 Jarvik Heart Inc.
6.1.12 Terumo Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Organ Type
Artificial Heart
Prosthetic Heart Valves
Ventricular Assist Devices
Cardiac Pacemakers
Artificial Kidney
Artificial Pancreas
Artificial Lungs
Cochlear Implants
Other Organ Types
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Bioinformatics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the global bioinformatics market include the increasing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, accelerating growth of proteomics and genomics, and increasing research on molecular biology and drug discovery. Owing to the aforementioned factors, the global bioinformatics market is expected to experience a boost during the forecast period.
Bioinformatics is gaining importance, as large amounts of data generated through techniques, like nucleic acid and protein sequencing, require data management and interpretation for future researches and medical purposes. Hence, increasing demand is expected to drive the bioinformatics market during the forecast period.
The demand for differentially expressed genes, computational epigenetics, meta-analysis of microarray data, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market.
Thus, technical advancements, along with the advent of the NGS technology, have helped in the development of bioinformatics tools for analyzing a great amount of data. This has contributed to the growth of the global bioinformatics market.
There is also little research that has been done in the field of bioinformatics to expedite decision-making in healthcare. Within clinical or medical informatics, there is a rich history of research on systems designed to help care providers and patients (healthcare consumers) and make optimal decisions surrounding diagnosis and management.
Scope of the Report
As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs.
Key Market Trends
Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period
Bioinformatics is an essential component in basic research and in the development of new concepts for diagnosis and therapy, as well as in clinical practice, in which these concepts are applied to treat patients. Some of the major drivers that help in the increasing demand for bioinformatics are, growing applications of bioinformatics in drug discovery and development and growing bioinformatics support in the development of personalized medicines and clinical diagnostics.
Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period
A large number of healthcare investments in the Asia-Pacific region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including China and India, are expected to propel the bioinformatics market in this region mainly.
Competitive Landscape
Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
4.2.2 Increasing Initiatives from Governments and Private Organizations
4.2.3 Accelerating Growth of Proteomics and Genomics
4.2.4 Increasing Research on Molecular Biology and Drug Discovery
4.3 Market Restraints
4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product and Services
5.1.1 Knowledge Management Tools
5.1.2 Bioinformatics Platform
5.1.2.1 Interventional/Surgical Simulators
5.1.2.2 Sequence Analysis Platform
5.1.2.3 Sequence Alignment Platform
5.1.2.4 Sequence Manipulation Platform
5.1.2.5 Structural and Functional Analysis Platform
5.1.2.6 Other Bioinformatics Platforms
5.1.3 Bioinformatics Services
5.1.3.1 Sequencing Services
5.1.3.2 Database and Management Services
5.1.3.3 Data Analysis
5.1.3.4 Other Bioinformatics Services
5.2 By Application
5.2.1 Microbial Genome
5.2.2 Gene Engineering
5.2.3 Drug Development
5.2.4 Personalized Medicine
5.2.5 Omics
5.2.6 Other Applications
5.3 By End User
5.3.1 Pharmaceutical
5.3.2 Animal Study
5.3.3 Agriculture
5.3.4 Forensic science
5.3.5 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Illumina Inc.
6.1.2 Life Technologies (Thermo Fischer Scientific)
6.1.3 Qiagen NV
6.1.4 Agilent Technologies
6.1.5 PerkinElmer
6.1.6 ABM
6.1.7 Accelrys Inc.
6.1.8 Geneva Bioinformatics SA
6.1.9 Ontoforce
6.1.10 Data4Cure
6.1.11 Life Map Sciences (Biotime)
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product and Services
Knowledge Management Tools
Bioinformatics Platform
Interventional/Surgical Simulators
Sequence Analysis Platform
Sequence Alignment Platform
Sequence Manipulation Platform
Structural and Functional Analysis Platform
Other Bioinformatics Platforms
Bioinformatics Services
Sequencing Services
Database and Management Services
Data Analysis
Other Bioinformatics Services
By Application
Microbial Genome
Gene Engineering
Drug Development
Personalized Medicine
Omics
Other Applications
By End User
Pharmaceutical
Animal Study
Agriculture
Forensic science
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Bioabsorbable Stents Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Đã xuất bản: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The global bioabsorbable stents market was valued at USD 112.14 million in 2018, and is estimated to be valued at USD 183.28 million in 2024, witnessing a CAGR of 8.53%. Factors that are driving the market include a high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population.
As per the report of the World Health Organization (WHO), it is seen that the number one cause of death across the world is cardiovascular disease. Furthermore, the WHO has estimated that in 2016, approximately 17.9 million people died due to cardiovascular diseases (CVDs) which represents 31% of the total global deaths, and 85% of these deaths were due to heart attack and stroke. As reported by the Australian Heart Foundation, cardiovascular disease (CVD) is a major cause of death in Australia, with 43,477 deaths being attributed to CVD in Australia in 2017. Cardiovascular disease kills one Australian every 12 minutes. Hence, this global rise in the prevalence of CVD is expected to fuel the market growth.
Scope of the Report
According to the report, the polymer-based or metal-based stents dissolve or get absorbed in the body, and are expected to overcome complications and risks associated with metallic stents.
Key Market Trends
Polymer-based Bioabsorbable Stents Sub-segment is Expected to hold its Highest Market Share in the Product Type Segment
In the product type segment of the market, polymer-based bioabsorbable stents are believed to have the largest market size and are expected to witness a CAGR of 8.95% in the forecast period.
Bioabsorbable stents (BAS)/polymer-based bioabsorbable stents are made of the materials that can completely dissolve or be absorbed in the body. These are used both in peripheral and coronary artery disease. Most of the bioabsorbable stents are made of polylactic acid that is a naturally dissolvable material. However, the polymer materials, such as polycarbonates, polyesters, corrodible metals, and bacterial-derived polymers are under investigation for developing the next-generation bioabsorbable stents. The risk of the in-stent restenosis using drug-eluting and metallic stents (DES) has raised the need for bioabsorbable stents. The BAS has a low rate of late-stent thrombosis (LST) and restenosis, which led to the acceptance of BAS for clinical purposes. The product Absorb GT1 Bioresorbable Vascular Scaffold System (BVS) from Abbott was the first absorbable stent for coronary artery disease that received FDA in 2016, and was commercially available in Europe from 2011. However, on September 14, 2017, Abbott announced the end of sales of the Absorb bioresorbable vascular scaffold, due to poor sales and safety concerns, which led to a strong negative impact on the market. However, owing to the increased significance of the same, this sub-segment is expected to register substantial growth in the coming future.
Europe Dominates the Market and is Expected to do the Same in the Forecast Period
Europe currently dominates the market for bioabsorbable stents and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased usage of bioabsorbable stents. There is a rise in the usage because the region has a large number of people suffering from cardiovascular diseases and there is a huge demand for technologically advanced treatment options for the same.
Competitive Landscape
The bioabsorbable stents market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at affordable prices. Companies, like Boston Scientific Corporation, Arterius Limited, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd, and Terumo Corporation, hold the substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 High Prevalence of Cardiovascular Diseases Globally
4.3.2 Steep Increase in Aging Population
4.3.3 Expanding Base of Obese Population
4.4 Market Restraints
4.4.1 Stringent Regulatory Scenario
4.4.2 High Device Cost
4.4.3 Safety Issues Related to Bioabsorbable Stents
4.5 Industry Attractiveness – Porter’s Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Polymer-based Bioabsorbable Stents
5.1.2 Metal-based Bioabsorbable Stents
5.2 By Application
5.2.1 Coronary Artery Disease
5.2.2 Peripheral Artery Disease
5.3 By Absorption Rate
5.3.1 Slow Absorption Rate
5.3.2 Fast Absorption Rate
5.4 By End User
5.4.1 Hospitals
5.4.2 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Arterius Limited
6.1.3 Elixir Medical Corporation
6.1.4 Kyoto Medical Planning Co. Ltd
6.1.5 Terumo Corporation
6.1.6 Abbott Laboratories Inc.
6.1.7 Amaranth Medical
6.1.8 Biotronik
6.1.9 Meril Life Sciences Pvt. Ltd
6.1.10 Reva Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
By Application
Coronary Artery Disease
Peripheral Artery Disease
By Absorption Rate
Slow Absorption Rate
Fast Absorption Rate
By End User
Hospitals
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America